Shana D Stites, Sharnita Midgett, Emily A Largent, Kristin Harkins, Rosalie Schumann, Pamela Sankar, Abba Krieger
{"title":"黑人成人阿尔茨海默氏症耻辱感调查研究:黑人身份与生物标记诊断的交叉性。","authors":"Shana D Stites, Sharnita Midgett, Emily A Largent, Kristin Harkins, Rosalie Schumann, Pamela Sankar, Abba Krieger","doi":"10.1080/13557858.2024.2385110","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>We urgently need to understand Alzheimer's disease (AD) stigma among Black adults. Black communities bear a disproportionate burden of AD, and recent advances in early diagnosis using AD biomarkers may affect stigma associated with AD. The goal of our study is to characterize AD stigma within our cohort of self-identified Black participants and test how AD biomarker test results may affect this stigma.</p><p><strong>Design: </strong>We surveyed a sample of 1,150 self-identified Black adults who were randomized to read a vignette describing a fictional person, who was described as either having a positive or negative biomarker test result. After reading the vignette, participants completed the modified <i>Family Stigma in Alzheimer's Disease Scale</i> (FS-ADS). We compared FS-ADS scores between groups defined by age, gender, and United States Census region. We examined interactions between these groupings and AD biomarker test result.</p><p><strong>Results: </strong>Participants over age 65 had lower scores (lower stigma) on all 7 FS-ADS domains compared to those under 65: <i>structural discrimination, negative severity attributions, negative aesthetic attributions, antipathy, support, pity,</i> and <i>social distance</i>. In the biomarker positive condition, worries about <i>structural discrimination</i> were greater than in the biomarker negative condition and statistically similar in the two age groups (DOR, 0.39 [95%CI, 0.22-0.69]). This pattern of results was similar for <i>negative symptom attributions</i> (DOR, 0.51 [95%CI, 0.28-0.90]).</p><p><strong>Conclusion: </strong>While older adults reported less AD stigma than younger adults, AD biomarker testing caused similarly high concerns about structural discrimination and negative severity attributions. Thus, use of AD biomarker diagnosis may increase AD stigma and exacerbate healthcare disparities known to effect AD diagnosis in some Black adults. Advances in AD diagnosis may interact with social and structural factors to differentially affect groups of Black adults.</p>","PeriodicalId":51038,"journal":{"name":"Ethnicity & Health","volume":" ","pages":"946-962"},"PeriodicalIF":2.6000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560502/pdf/","citationCount":"0","resultStr":"{\"title\":\"A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis.\",\"authors\":\"Shana D Stites, Sharnita Midgett, Emily A Largent, Kristin Harkins, Rosalie Schumann, Pamela Sankar, Abba Krieger\",\"doi\":\"10.1080/13557858.2024.2385110\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>We urgently need to understand Alzheimer's disease (AD) stigma among Black adults. Black communities bear a disproportionate burden of AD, and recent advances in early diagnosis using AD biomarkers may affect stigma associated with AD. The goal of our study is to characterize AD stigma within our cohort of self-identified Black participants and test how AD biomarker test results may affect this stigma.</p><p><strong>Design: </strong>We surveyed a sample of 1,150 self-identified Black adults who were randomized to read a vignette describing a fictional person, who was described as either having a positive or negative biomarker test result. After reading the vignette, participants completed the modified <i>Family Stigma in Alzheimer's Disease Scale</i> (FS-ADS). We compared FS-ADS scores between groups defined by age, gender, and United States Census region. We examined interactions between these groupings and AD biomarker test result.</p><p><strong>Results: </strong>Participants over age 65 had lower scores (lower stigma) on all 7 FS-ADS domains compared to those under 65: <i>structural discrimination, negative severity attributions, negative aesthetic attributions, antipathy, support, pity,</i> and <i>social distance</i>. In the biomarker positive condition, worries about <i>structural discrimination</i> were greater than in the biomarker negative condition and statistically similar in the two age groups (DOR, 0.39 [95%CI, 0.22-0.69]). This pattern of results was similar for <i>negative symptom attributions</i> (DOR, 0.51 [95%CI, 0.28-0.90]).</p><p><strong>Conclusion: </strong>While older adults reported less AD stigma than younger adults, AD biomarker testing caused similarly high concerns about structural discrimination and negative severity attributions. Thus, use of AD biomarker diagnosis may increase AD stigma and exacerbate healthcare disparities known to effect AD diagnosis in some Black adults. Advances in AD diagnosis may interact with social and structural factors to differentially affect groups of Black adults.</p>\",\"PeriodicalId\":51038,\"journal\":{\"name\":\"Ethnicity & Health\",\"volume\":\" \",\"pages\":\"946-962\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11560502/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Ethnicity & Health\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1080/13557858.2024.2385110\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/7/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"ETHNIC STUDIES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Ethnicity & Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/13557858.2024.2385110","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/7/30 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"ETHNIC STUDIES","Score":null,"Total":0}
A survey study of Alzheimer's stigma among Black adults: intersectionality of Black identity and biomarker diagnosis.
Objective: We urgently need to understand Alzheimer's disease (AD) stigma among Black adults. Black communities bear a disproportionate burden of AD, and recent advances in early diagnosis using AD biomarkers may affect stigma associated with AD. The goal of our study is to characterize AD stigma within our cohort of self-identified Black participants and test how AD biomarker test results may affect this stigma.
Design: We surveyed a sample of 1,150 self-identified Black adults who were randomized to read a vignette describing a fictional person, who was described as either having a positive or negative biomarker test result. After reading the vignette, participants completed the modified Family Stigma in Alzheimer's Disease Scale (FS-ADS). We compared FS-ADS scores between groups defined by age, gender, and United States Census region. We examined interactions between these groupings and AD biomarker test result.
Results: Participants over age 65 had lower scores (lower stigma) on all 7 FS-ADS domains compared to those under 65: structural discrimination, negative severity attributions, negative aesthetic attributions, antipathy, support, pity, and social distance. In the biomarker positive condition, worries about structural discrimination were greater than in the biomarker negative condition and statistically similar in the two age groups (DOR, 0.39 [95%CI, 0.22-0.69]). This pattern of results was similar for negative symptom attributions (DOR, 0.51 [95%CI, 0.28-0.90]).
Conclusion: While older adults reported less AD stigma than younger adults, AD biomarker testing caused similarly high concerns about structural discrimination and negative severity attributions. Thus, use of AD biomarker diagnosis may increase AD stigma and exacerbate healthcare disparities known to effect AD diagnosis in some Black adults. Advances in AD diagnosis may interact with social and structural factors to differentially affect groups of Black adults.
期刊介绍:
Ethnicity & Health
is an international academic journal designed to meet the world-wide interest in the health of ethnic groups. It embraces original papers from the full range of disciplines concerned with investigating the relationship between ’ethnicity’ and ’health’ (including medicine and nursing, public health, epidemiology, social sciences, population sciences, and statistics). The journal also covers issues of culture, religion, gender, class, migration, lifestyle and racism, in so far as they relate to health and its anthropological and social aspects.